Communications publiées lors de congrès ou colloques nationaux et internationaux (12)
  1. 5. Vergara Panos, C., Houben, S., Vanden Dries, V., Yilmaz, Z., Suain, V., De Decker, R., Duyckaerts, C., Boom, A., Leroy, K., Ando, K., & Brion, J. P. (2016). PHF-tau propagation in the presence of Amyloid ß pathology. Front. Aging Neurosci. (p. 219818) 6TH BELGIAN BRAIN CONGRESS(6: 2016-10-08: Mons, Belgium). doi:10.3389/conf.fnagi.2016.03.00017
  2. 6. Leroy, K., Ando, K., Heraud, C., & Brion, J. P. (2015). Plaques amyloïdes et pathologie tau: modélisation de leur interaction dans des modèles murins développant les lésions de la maladie d’Alzheimer. Morphologie. Vol. 99 (pp. 97-98) 97e congrès de l'Association des Morphologistes(97: 2015-01-29 to 2015-01-31: Bruxelles, Belgium).
  3. 7. Brion, J. P., Ando, K., Heraud, C., Leroy, K., & Stygelbout, V. (2014). ABNORMAL PROCESSING AND MISFOLDING OF TAU IS MODULATED BY ENDOGENOUS TAU AND MUTANT APP/PS1 BUT NOT BY ENDOGENOUS APP IN TAU TRANSGENIC MICE. In Alzheimer's & Dementia: The Journal of the Alzheimer's Association: Vol. 10 (4 ed., p. 785) Elsevier.
  4. 8. Brion, J. P., Heraud, C., Leroy, K., Ando, K., Suain, V., Dedecker, R., Authelet, M., Laporte, V., Pierrot, N., Octave, J. N., & Yilmaz, Z. (2013). Wild-type and mutant tau expression affects APP processing. In Alzheimer's & Dementia: The Journal of the Alzheimer's Association: Vol. 9 (4 ed., p. 142) Elsevier.
  5. 9. Leroy, K., Ando, K., Laporte, V., Dedecker, R., Suain, V., Authelet, M., Heraud, C., Pierrot, N., Yilmaz, Z., Octave, J. N., & Brion, J. P. (2012). Tau deletion rescues neuronal death in APP/PS1 mice. In Alzheimer's & Dementia: The journal of the Alzheimer's association: Vol. 8 (4 ed., p. 87) Elsevier.
  6. 10. Brion, J. P., Ando, K., Heraud, C., Leroy, K., & Morel, M. (2011). Tau and GSK3beta. Alzheimer's & Dementia: The journal of the Alzheimer's association. Vol. 7 (4 ed., p. 676) AAIC 2011(2011-07-16 to 2011-07-21: Paris).
  7. 11. Brion, J. P., Leroy, K., Ando, K., Bretteville, A., Yilmaz, Z., Authelet, M., Dedecker, R., & Buée, L. (2008). Subacute per OS lithium treatment decreases Tau phosphorylation and neurofibrillary tangles load in G272V/P301S mutant Tau transgenic mice. Alzheimer's & Dementia: The Journal of Alzheimer's Association. Vol. 4 (4 ed., p. 185) ICAD 2008(2008-07-26 to 2008-07-31: Chicago, USA).
  8. 12. Anderton, B., Betts, J., Blackstock, W. P., Brion, J. P., Chapman, S., Connell, J., Dayanandan, R., Gallo, J. M., Gibb, G. M., Hanger, D., Hutton, M., Kardalinou, E., Leroy, K., Lovestone, S., Mack, T., Reynolds, C. H., & Van Slegtenhorst, M. (2000). Sites of phosphorylation in tau and factors affecting their regulation. In C. O'Neil & B. Anderton (Eds.), Neuronal signal transduction and Alzheimer's disease.: Vol. 67 (pp. 73-80) U.K.: Portland Press.
    9.   Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (1)
  9. 1. Ando, K., Ferlini, L., Suain, V., Yilmaz, Z., Mansour, S., Le Ber, I., Bouchard, C., Leroy, K., Durr, A., Clot, F., Sarazin, M., & Bier, J. C. (2020). De novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia. Acta neuropathologica communications, 8(1), 94. doi:10.1186/s40478-020-00977-8
    10.   Participations à des congrès et colloques internationaux (39)
  10. 1. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Mansour, S., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau do not spread tau pathology to the brain via the retinotectal pathway after intraocular injection in mouse models. Paper session presented at International conference on Alzheimer and Parkinson's diseases (15-22 March 2022: Barcelona).
  11. 2. De Fisenne, M.-A., Houben, S., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2022). Intravenous injection of PHF-Tau proteins from Alzheimer Brain exacerbates neuroinflammation, Amyloid beta, and tau pathologies in 5XFAD transgenic mice.. Vol. 145 (p. 411) Abstract session presented at International conference on Alzheimer and Parkinson's diseases(15-20 Mars 2022: Barcelona).
  12. 3. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Mansour, S., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau do not spread tau pathology to the brain via the retinotectal pathway after intraocular injection in mouse models.. Vol. 130 (p. 176) Abstract session presented at International conference on Alzheimer and Parkinson’s diseases(15-22 mars 2022: Barcelona).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 Suivant >>